##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H154-301222-ROCHE_S102_R
1	120724154	.	N	<DEL>	.	.	Type=Loss;Targets=21;Samples2=2;Span=116508;GeneNames=NBPF26,NOTCH2NLR;GeneIDs=101929796,101060684;Aliases=NOTCH2NLD;Genes=2;TranscriptNameClinicallyRelevant=NM_001395637.1,NM_001396072.1;OverlappingExonsClinicallyRelevant=All,All;HGVSg=NC_000001.11:g.120724154_120840661del;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(1)p11.2;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;END=120840661	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:34.7635:-1.84075:0.223843:7.11751209982662e-16:NBPF26,NOTCH2NLR::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes:1
1	207563854	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=4;Span=4277;GeneNames=CR1;GeneIDs=1378;Aliases=C3BR,C4BR,CD35,KN;Genes=1;TranscriptNameClinicallyRelevant=NM_000651.6;OverlappingExonsClinicallyRelevant=22-25;HGVSg=NC_000001.11:g.207563854_207568130dup;HGVScClinicallyRelevant=NM_000651.6:c.3587-10_4171+88dup;HGVSpClinicallyRelevant=NP_000642.3:p.V1196_L1390dup;ISCNCytobandNotation=dup(1)q32.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;Region2=1:207558604-207567633;Span3=9030;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=207568130	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:205.681:1.80854:1.41583:0.000119112898605259:CR1::CR1:NM_000651.6:Benign:2L0ThiscnvpartiallyoverlapstheCR1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	212830174	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=6;Span=5984;GeneNames=SPATA45;GeneIDs=149643;Aliases=C1orf227;Genes=1;TranscriptNameClinicallyRelevant=NM_001024601.3;OverlappingExonsClinicallyRelevant=2-3;HGVSg=NC_000001.11:g.212830174_212836157del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(1)q32.3;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=1:212824043-212837094,1:212826359-212844783,1:212830086-212838470;Span2=13052,18425,8385;OverlapType=Within Region,Within Region,Within Region;Name=gssvL7587,gssvL7586,gssvL7589;Frequency=0.0238,0.0236,0.0098;Type2=Loss,Loss,Loss;Region2=1:212813954-212839702,1:212829027-212840323,1:212831114-212833055,1:212831114-212840709,1:212831522-212839798,1:212831522-212839798;Span3=25749,11297,1942,9596,8277,8277;OverlapType2=Within Region,Within Region,Contains Region,Partial Overlap,Partial Overlap,Partial Overlap;Type3=Deletion,Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.0568047,0.0227273,0.00168947,0.0113195,0.025,0.0555556;DeletionFrequency=0.0568047,0.0227273,0.00168947,0.0113195,0.025,0.0555556;DuplicationFrequency=0,0,0,0,0,0;END=212836157	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:45.8874:-4.14963:0.430323:2.08874984997329e-08:SPATA45::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
2	89851851	.	N	<DEL>	.	.	Type=Loss;Targets=28;Samples2=9;Span=383588;Region=2:89885745-90282587,2:89896137-90155813,2:89938782-90021074,2:90005822-90201947,2:90075861-90282555,2:90095425-90228249,2:90149665-90228240;Span2=396843,259677,82293,196126,206695,132825,78576;OverlapType=Partial Overlap,Contains Region,Contains Region,Contains Region,Partial Overlap,Contains Region,Contains Region;Name=gssvL64385,gssvL64388,gssvL64414,gssvL64394,gssvL64393,gssvL64402,gssvL64420;Frequency=0.0469,0.0035,0.1094,0.0045,0.0059,0.0015,0.0185;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=2:90005823-90161035,2:90054128-90226273,2:90095097-90262422;Span3=155213,172146,167326;OverlapType2=Contains Region,Contains Region,Partial Overlap;Type3=Deletion,Deletion,Deletion;Frequency2=0.131111,0.00118343,0.013009;DeletionFrequency=0.131111,0.00118343,0.013009;DuplicationFrequency=0,0,0;END=90235438	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:79.321:-1.49113:0.620132:4.47554031115328e-14:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2F-1ThecnvdoesnotincludeanyproteincodinggenesoutsideoftheknownhaplobenignregionISCA-46578inClinGenDosageSensitivity.,3A0Thiscnvoverlaps0proteincodinggenes:1
2	99147420	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=3;Span=33571;GeneNames=C2orf15,LIPT1,MITD1,TSGA10;GeneIDs=80705,150590,51601,129531;Aliases=CEP4L,CT79,SPGF26;Genes=4;TranscriptNameClinicallyRelevant=NM_144706.4,NM_145199.3,NM_138798.3,NM_025244.4;OverlappingExonsClinicallyRelevant=3-4,All,All,1;HGVSg=NC_000002.12:g.99147420_99180990dup;HGVScClinicallyRelevant=.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(2)q11.2;SequenceOntologyClinicallyRelevant=.,.,.,.;RegionClinicallyRelevant=.,.,.,.;END=99180990	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:140.162:4.37661:1.41618:3.48300756537484e-36:C2orf15,LIPT1,MITD1,TSGA10::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps4proteincodinggenes:3
4	85930926	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=120;GeneNames=ARHGAP24;GeneIDs=83478;Aliases=FILGAP,RC-GAP72,RCGAP72,p73,p73RhoGAP;Genes=1;TranscriptNameClinicallyRelevant=NM_001025616.3;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000004.12:g.85930926_85931045del;HGVScClinicallyRelevant=NM_001025616.3:c.391+7156_391+7275del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(4)q21.23;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;END=85931045	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:22.175:-4.05109:0.33069:0.000114892624346805:ARHGAP24::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:1
5	140842883	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=15;Span=15739;GeneNames=PCDHA1,PCDHA2,PCDHA3,PCDHA4,PCDHA5,PCDHA6,PCDHA7,PCDHA8,PCDHA9,PCDHA10;GeneIDs=56147,56146,56145,56144,56143,56142,56141,56140,9752,56139;Aliases=PCDH-ALPHA1;Genes=10;TranscriptNameClinicallyRelevant=NM_018900.4,NM_018905.3,NM_018906.3,NM_018907.4,NM_018908.3,NM_018909.4,NM_018910.3,NM_018911.3,NM_031857.2,NM_018901.4;OverlappingExonsClinicallyRelevant=.,.,.,.,.,.,.,1,1,1;HGVSg=NC_000005.10:g.140842883_140858621del;HGVScClinicallyRelevant=NM_018900.4:c.2394+54199_2394+69937del,NM_018905.3:c.2388+45531_2388+61269del,NM_018906.3:c.2394+39292_2394+55030del,NM_018907.4:c.2385+33311_2385+49049del,NM_018908.3:c.2352+18756_2352+34494del,NM_018909.4:c.2394+12398_2394+28136del,NM_018910.3:c.2355+6145_2355+21883del,NM_018911.3:c.1562_2394+14906del,NM_031857.2:c.1_2394+7732del,NM_018901.4:c.1_2388+185del;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,NP_061734.1:p.?,.,.;ISCNCytobandNotation=del(5)q31.3;SequenceOntologyClinicallyRelevant=intron_variant,intron_variant,intron_variant,intron_variant,intron_variant,intron_variant,intron_variant,splice_donor_variant,transcript_ablation,transcript_ablation;RegionClinicallyRelevant=intron,intron,intron,intron,intron,intron,intron,exon,exon,exon;Region=5:140835344-140852254,5:140839141-140874533,5:140841349-140862645,5:140843360-140852254,5:140847633-140857963;Span2=16911,35393,21297,8895,10331;OverlapType=Partial Overlap,Within Region,Within Region,Contains Region,Contains Region;Name=gssvL102656,gssvL102653,gssvL102655,gssvL102661,gssvL102660;Frequency=0.0106,0.0187,0.0711,0.0527,0.0505;Type2=Loss,Loss,Loss,Loss,Loss;Region2=5:140842553-140859346,5:140842565-140859300,5:140843567-140848915,5:140844252-140852254,5:140848187-140857112,5:140850767-140855647;Span3=16794,16736,5349,8003,8926,4881;OverlapType2=Within Region,Within Region,Contains Region,Contains Region,Contains Region,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.0766385,0.144444,0.0819239,0.00743369,0.00118343,0.0803383;DeletionFrequency=0.0766385,0.144444,0.0819239,0.00743369,0.00118343,0.0803383;DuplicationFrequency=0,0,0,0,0,0;END=140858621	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:105.601:-2.72549:0.582126:1.76883176024112e-10:PCDHA1,PCDHA2,PCDHA3,PCDHA4,PCDHA5,PCDHA6,PCDHA7,PCDHA8,PCDHA9,PCDHA10::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps10proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
5	176097307	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=1758;GeneNames=FAM153B;GeneIDs=202134;Genes=1;TranscriptNameClinicallyRelevant=NM_001265615.2;OverlappingExonsClinicallyRelevant=7-9;HGVSg=NC_000005.10:g.176097307_176099064dup;HGVScClinicallyRelevant=NM_001265615.2:c.211-48_331+19dup;HGVSpClinicallyRelevant=NP_001252544.1:p.G111Efs*21;ISCNCytobandNotation=dup(5)q35.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=176099064	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:102.675:2.29958:1.41756:0.00015097922980996:FAM153B::FAM153B:NM_001265615.2:VUS:2L0ThiscnvpartiallyoverlapstheFAM153Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	31996519	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=6;Span=802;GeneNames=C4A;GeneIDs=720;Aliases=C4,C4A2,C4A3,C4A4,C4A6,C4AD,C4S,CO4,CPAMD2,RG;Genes=1;TranscriptNameClinicallyRelevant=NM_007293.3;OverlappingExonsClinicallyRelevant=28-30;HGVSg=NC_000006.12:g.31996519_31997320dup;HGVScClinicallyRelevant=NM_007293.3:c.3595_4077+9dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=31997320	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:154.831:2.8108:3.33677:0.000155576238377331:C4A::C4A:NM_007293.3:Benign:2L0ThiscnvpartiallyoverlapstheC4Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	32038324	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=5572;GeneNames=CYP21A2,TNXB;GeneIDs=1589,7148;Aliases=CA21H,CAH1,CYP21,CYP21B,P450c21B;Genes=2;TranscriptNameClinicallyRelevant=NM_000500.9,NM_019105.8;OverlappingExonsClinicallyRelevant=All,35-44;HGVSg=NC_000006.12:g.32038324_32043895dup;HGVScClinicallyRelevant=.,NM_019105.8:c.11381-3_12729dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(6)p21.33;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;Region=6:32023812-32048749;Span2=24938;OverlapType=Within Region;Name=gssvG32066;Frequency=0.1628;Type2=Gain;Region2=6:32023829-32048301;Span3=24473;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.15;DeletionFrequency=0;DuplicationFrequency=0.15;END=32043895	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:127.438:2.63229:1.36864:4.44292438232377e-14:CYP21A2,TNXB::TNXB:NM_019105.8:Benign:2L0ThiscnvpartiallyoverlapstheTNXBgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	160613095	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=1;Span=37452;GeneNames=LPA;GeneIDs=4018;Aliases=AK38,APOA,LP;Genes=1;TranscriptNameClinicallyRelevant=NM_005577.4;OverlappingExonsClinicallyRelevant=2-15;HGVSg=NC_000006.12:g.160613095_160650546dup;HGVScClinicallyRelevant=NM_005577.4:c.50-49_2280dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(6)q26;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=6:160595829-160662125;Span2=66297;OverlapType=Within Region;Name=gssvG33438;Frequency=0.0376;Type2=Gain;END=160650546	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:377.509:1.81768:1.86564:4.55780694359901e-06:LPA::LPA:NM_005577.4:Benign:2L0ThiscnvpartiallyoverlapstheLPAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
7	72941827	.	N	<DEL>	.	.	Type=Loss;Targets=7;Samples2=1;Span=24339;GeneNames=NSUN5P2,POM121,TRIM74;GeneIDs=9883,260294,378108;Aliases=P145,POM121A;Genes=3;TranscriptNameClinicallyRelevant=NR_033323.3,NM_001387691.1,NM_198853.3;OverlappingExonsClinicallyRelevant=All,11-13,2-5;HGVSg=NC_000007.14:g.72941827_72966165del;HGVScClinicallyRelevant=.,NM_001387691.1:c.1844-10_3750del,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=del(7)q11.23;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.;RegionClinicallyRelevant=.,exon,.;Region2=7:72959648-72966868;Span3=7221;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.00118343;DeletionFrequency=0.00118343;DuplicationFrequency=0;END=72966165	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:41.8527:-3.08049:0.479514:6.49667613032008e-15:NSUN5P2,POM121,TRIM74::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes:1
9	114323131	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=1;Span=6890;GeneNames=ORM1,ORM2;GeneIDs=5004,5005;Aliases=AGP-A,AGP1,HEL-S-153w,ORM;Genes=2;TranscriptNameClinicallyRelevant=NM_000607.4,NM_000608.4;OverlappingExonsClinicallyRelevant=All,1;HGVSg=NC_000009.12:g.114323131_114330020dup;HGVScClinicallyRelevant=.,NM_000608.4:c.1_114+2dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(9)q32;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;Region=9:114316410-114336003,9:114323737-114335437;Span2=19594,11701;OverlapType=Within Region,Partial Overlap;Name=gssvG40321,gssvG40322;Frequency=0.0506,0.1095;Type2=Gain,Gain;Region2=9:114320742-114335868;Span3=15127;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.1;DeletionFrequency=0;DuplicationFrequency=0.1;END=114330020	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:212.539:2.59227:1.73886:5.67385806983585e-11:ORM1,ORM2::ORM2:NM_000608.4:Benign:2E0TheCNVissmallerthanthetriplobenignregionISCA-46636inClinGenDosageSensitivityandpotentiallyinteruptsprotein-codinggeneORM2.,2L0ThiscnvpartiallyoverlapstheORM2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
10	47468816	.	N	<DEL>	.	.	Type=Loss;Targets=16;Samples2=3;Span=54719;GeneNames=AGAP9,ANXA8,BMS1P2-AGAP9,FAM25G;GeneIDs=653145,100133093,113939912,642517;Aliases=ANX8,CH17-360D5.2;Genes=4;TranscriptNameClinicallyRelevant=NM_001190810.1,NM_001040084.3,NR_160415.1,NM_001137549.2;OverlappingExonsClinicallyRelevant=All,All,9-16,All;HGVSg=NC_000010.11:g.47468816_47523534del;HGVScClinicallyRelevant=.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=del(10)q11.22;SequenceOntologyClinicallyRelevant=.,.,.,.;RegionClinicallyRelevant=.,.,.,.;Region=10:47490407-47526257;Span2=35851;OverlapType=Partial Overlap;Name=gssvL12174;Frequency=0.403;Type2=Loss;END=47523534	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:32.8807:-1.77917:0.363084:1.02021202073754e-11:AGAP9,ANXA8,BMS1P2-AGAP9,FAM25G::AGAP9:NM_001190810.1:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46443inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
12	52515753	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=KRT5;GeneIDs=3852;Aliases=CK5,DDD,DDD1,EBS1,EBS2,EBS2A,EBS2B,EBS2C,EBS2D,EBS2E,EBS2F,K5,KRT5A;Genes=1;TranscriptNameClinicallyRelevant=NM_000424.4;OverlappingExonsClinicallyRelevant=8;HGVSg=NC_000012.12:g.52515753_52515872dup;HGVScClinicallyRelevant=NM_000424.4:c.1440-40_1474+45dup;HGVSpClinicallyRelevant=NP_000415.2:p.S492Yfs*63;ISCNCytobandNotation=dup(12)q13.13;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=52515872	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:77.9583:4.11559:1.66339:8.93993615069464e-05:KRT5::KRT5:NM_000424.4:VUS:2L0ThiscnvpartiallyoverlapstheKRT5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	19421620	.	N	<DUP>	.	.	Type=Gain;Targets=18;Samples2=1;Span=515042;GeneNames=LOC101929572,OR4K1,OR4K2,OR4K3,OR4K5,OR4M1,OR4N2,OR4Q3,OR11H2,POTEG;GeneIDs=404785,101929572,79334,441669,441670,390429,283617,390431,79317,79544;Aliases=A26C2,ACTBL1,CT104.4,POTE-14,POTE14,POTE14alpha,POTE22;Genes=10;TranscriptNameClinicallyRelevant=NR_110504.1,NM_001004063.3,NM_001005501.2,NR_145507.2,NM_001005483.1,NM_001005500.2,NM_001004723.3,NM_172194.1,NM_001197287.2,NM_001005356.3;OverlappingExonsClinicallyRelevant=2,All,All,All,All,All,All,All,All,1-6;HGVSg=NC_000014.9:g.19421620_19936661dup;HGVScClinicallyRelevant=.,.,.,.,.,.,.,.,.,NM_001005356.3:c.1_1126+4dup;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.,.,.;ISCNCytobandNotation=dup(14)q11.2;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.,.,.,transcript_ablation;RegionClinicallyRelevant=.,.,.,.,.,.,.,.,.,exon;Region=14:19215688-19871283,14:19437931-19841680,14:19709051-19977459,14:19716201-19874569,14:19791588-19956892;Span2=655596,403750,268409,158369,165305;OverlapType=Partial Overlap,Contains Region,Partial Overlap,Contains Region,Partial Overlap;Name=gssvG10811,gssvG10814,gssvG10817,gssvG10821,gssvG10825;Frequency=0.0282,0.0215,0.0677,0.0004,0.0009;Type2=Gain,Gain,Gain,Gain,Gain;Region2=14:18955962-19837619,14:19704993-19947632,14:19709052-19956594,14:19726698-19833781;Span3=881658,242640,247543,107084;OverlapType2=Partial Overlap,Partial Overlap,Partial Overlap,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.0190911,0.415273,0.531111,0.125;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.0190911,0.415273,0.531111,0.125;END=19936661	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:451.071:2.41192:1.78625:1.29923403186066e-22:LOC101929572,OR4K1,OR4K2,OR4K3,OR4K5,OR4M1,OR4N2,OR4Q3,OR11H2,POTEG::OR4K1:NM_001004063.3:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46675inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps8proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
15	30553791	.	N	<DUP>	.	.	Type=Gain;Targets=12;Samples2=10;Span=50442;GeneNames=ARHGAP11B-DT,DNM1P50,GOLGA8H,GOLGA8Q,ULK4P2;GeneIDs=727909,101927579,100288380,102725021,728498;Genes=5;TranscriptNameClinicallyRelevant=NR_157594.1,NR_145478.1,NM_001282490.2,NM_001355476.2,NR_027470.1;OverlappingExonsClinicallyRelevant=7,All,1,2-19,All;HGVSg=NC_000015.10:g.30553791_30604232dup;HGVScClinicallyRelevant=.,.,NM_001282490.2:c.1_48+59dup,NM_001355476.2:c.49-1_1899dup,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(15)q13.2;SequenceOntologyClinicallyRelevant=.,.,transcript_ablation,transcript_ablation,.;RegionClinicallyRelevant=.,.,exon,exon,.;END=30604232	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:122.315:1.21342:1.53468:6.31407598751404e-05:ARHGAP11B-DT,DNM1P50,GOLGA8H,GOLGA8Q,ULK4P2::GOLGA8H:NM_001282490.2:Benign:2L0ThiscnvpartiallyoverlapstheGOLGA8Hgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
17	18476854	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=7;Span=49978;GeneNames=FAM106A,LGALS9C,USP32P2;GeneIDs=654346,220594,80039;Aliases=Gal-9B;Genes=3;TranscriptNameClinicallyRelevant=NR_170998.1,NM_001040078.3,NR_003554.1;OverlappingExonsClinicallyRelevant=All,All,All;HGVSg=NC_000017.11:g.18476854_18526831dup;HGVScClinicallyRelevant=.,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=.,.,.;RegionClinicallyRelevant=.,.,.;Region=17:18374859-18523775,17:18386078-18606844,17:18442810-18523775,17:18452207-18494397;Span2=148917,220767,80966,42191;OverlapType=Partial Overlap,Within Region,Partial Overlap,Partial Overlap;Name=gssvG16058,gssvG16055,gssvG16067,gssvG16078;Frequency=0.0004,0.0177,0.0774,0.0052;Type2=Gain,Gain,Gain,Gain;Region2=17:18494519-18538496;Span3=43978;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=18526831	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:209.377:1.53224:1.50955:3.86150381287698e-06:FAM106A,LGALS9C,USP32P2::LGALS9C:NM_001040078.3:Benign:2B0WhiletheCNVoverlapstheLGALS9CgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37418inClinGenDosageSensitivity.,2F-1AllofthegenesinthecnvarecontainedinthetriplobenignregionISCA-46704inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
21	43065192	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=6;Span=2646;GeneNames=CBS;GeneIDs=875;Aliases=CBSL,HIP4;Genes=1;TranscriptNameClinicallyRelevant=NM_000071.3;OverlappingExonsClinicallyRelevant=5-8;HGVSg=NC_000021.9:g.43065192_43067837del;HGVScClinicallyRelevant=NM_000071.3:c.316+672_736+11del;HGVSpClinicallyRelevant=NP_000062.1:p.L106_G246delinsW;ISCNCytobandNotation=del(21)q22.3;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;END=43067837	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-2.45681:0:5.03575925810542e-05:CBS::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:0
22	25231594	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=128507;GeneNames=CRYBB2,IGLL3P;GeneIDs=1415,91353;Aliases=CCA2,CRYB2,CRYB2A,CTRCT3,D22S665;Genes=2;TranscriptNameClinicallyRelevant=NM_000496.3,NR_029395.1;OverlappingExonsClinicallyRelevant=6,All;HGVSg=NC_000022.11:g.25231594_25360100dup;HGVScClinicallyRelevant=NM_000496.3:c.450-10_618dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(22)q11.23;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=22:25223067-25612136,22:25248860-25362974,22:25307110-25437332;Span2=389070,114115,130223;OverlapType=Within Region,Partial Overlap,Partial Overlap;Name=gssvG24410,gssvG24416,gssvG24415;Frequency=0.0399,0.0127,0.0613;Type2=Gain,Gain,Gain;Region2=22:25268019-25310951;Span3=42933;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.000168947;DeletionFrequency=0;DuplicationFrequency=0.000168947;END=25360100	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:282.758:3.80942:1.60573:3.83719559379204e-16:CRYBB2,IGLL3P::CRYBB2:NM_000496.3:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46732inClinGenDosageSensitivitybutincludesadditionalmaterial.,2L0ThiscnvpartiallyoverlapstheCRYBB2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
Y	6866016	.	N	<DEL>	.	.	Type=Loss;Targets=22;Samples2=1;Span=225526;GeneNames=AMELY,TBL1Y;GeneIDs=266,90665;Aliases=AMGL,AMGY;Genes=2;TranscriptNameClinicallyRelevant=NM_001143.2,NM_033284.2;OverlappingExonsClinicallyRelevant=All,All;HGVSg=NC_000024.10:g.6866016_7091541del;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(Y)p11.2;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;END=7091541	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-5.24953:0:1.0125422579782e-122:AMELY,TBL1Y::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes:0
